SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-053515
Filing Date
2024-06-18
Accepted
2024-06-18 07:00:32
Documents
15
Period of Report
2024-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0207508-8k_pluri.htm   iXBRL 8-K 42397
2 SHARE PURCHASE AGREEMENT, DATED JUNE 12, 2024, BY AND AMONG EVER AFTER AND THE I ea020750801ex10-1_pluri.htm EX-10.1 165416
3 AMENDED AND RESTATED TECHNOLOGY LICENSE AGREEMENT, DATED JUNE 12, 2024, BETWEEN ea020750801ex10-2_pluri.htm EX-10.2 120512
  Complete submission text file 0001213900-24-053515.txt   565495

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE plur-20240612.xsd EX-101.SCH 3030
5 XBRL LABEL FILE plur-20240612_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE plur-20240612_pre.xml EX-101.PRE 22369
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0207508-8k_pluri_htm.xml XML 3679
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
Pluri Inc. (Filer) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31392 | Film No.: 241050154
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)